Skip to main content
Smart Investors Daily
HCA Healthcare, Inc. logo

NYSE · HCA

HCA Healthcare, Inc.

Healthcare · Medical - Care Facilities

$432.20

Up+$6.97 (+1.61%)

Updated Oct 7, 2026, 9:23 PM

SID Score

6.4/10

Composite research score

Smart Money

62/100

Neutral

Market cap
117.06B
P/E ratio
18.34
Dividend yield
0.82%
52-week range
$353.99 – $556.52
Volume
999.19K
Avg. volume
1.41M

Price performance · HCA

HCA price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Oct 6, 2026

HCA closed at $432.20 after 21 trading sessions, up 7.51% for the selected period.

Last close
$432.20
Period change
+7.51%
Period low
$402.02
Period high
$438.12
Daily close
View OHLC price history
HCA OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 6, 2026$433.61$438.11$429.485$432.20999.19K
Oct 5, 2026$426.70$437.27$426.00$434.921.15M
Oct 2, 2026$425.78$430.22$424.23$426.69929.81K
Oct 1, 2026$427.25$434.46$422.45$423.391.1M
Sep 30, 2026$430.25$434.074$425.96$426.741.24M
Sep 29, 2026$430.07$433.13$426.6052$431.63883.89K
Sep 28, 2026$431.16$443.145$431.16$432.601.11M
Sep 25, 2026$421.59$435.78$420.00$435.611.02M
Sep 24, 2026$437.36$442.21$423.39$423.481.05M
Sep 23, 2026$441.42$446.36$433.83$436.481.31M
Sep 22, 2026$426.37$442.52$426.37$438.121.5M
Sep 21, 2026$427.75$434.07$423.43$425.971.42M
Sep 18, 2026$429.17$436.14$425.37$427.715.45M
Sep 17, 2026$431.99$433.51$426.52$429.041.19M
Sep 16, 2026$420.69$433.70$420.00$430.431.37M
Sep 15, 2026$419.00$426.22$409.735$423.821.26M
Sep 14, 2026$429.96$433.80$420.00$425.491.31M
Sep 11, 2026$423.79$429.42$420.79$426.941.32M
Sep 10, 2026$422.61$426.81$415.04$421.211.41M
Sep 9, 2026$398.47$426.83$396.00$421.832.15M
Sep 8, 2026$401.55$411.75$397.60$402.021.76M

Latest HCA news

The latest Smart Investors Daily articles mentioning HCA.

HCA research

Overview

Company profile and research snapshot.

Company profile

HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2024, the firm owned and operated 190 hospitals, 124 freestanding outpatient surgery centers, and a broad network of physician offices, urgent-care clinics, and freestanding emergency rooms across 20 states and a small foothold in England.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$483.33
Implied upside
—
Analysts
22
HCA recent ratings
DateFirmRatingTarget
Sep 23, 2026BMO CapitalOutperform—
Sep 18, 2026Leerink PartnersOutperform—
Sep 8, 2026RBC CapitalOutperform—
Aug 20, 2026JP MorganNeutral—
Aug 3, 2026Wells FargoEqual-Weight—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 29, 2026

HCA Healthcare Presents 2026 Awards of Distinction

NASHVILLE, Tenn., September 29, 2026--HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, today presented its annual HCA Healthcare Awards of Distinction at a ceremony in Nashville, Tennessee. The HCA Healthcare Awards of Distinction, which include the Frist Humanitarian Award and the Excellence in Nursing Award, are the highest honors HCA Healthcare bestows on colleagues, nurses, physicians and volunteers, recognizing individuals who exemplify the organization’s c

Yahoo · Sep 29, 2026

Can HCA Healthcare (HCA) Overcome Healthcare’s Margin Pressures?

On September 22, BMO Capital analyst Sean Dodge initiated coverage of HCA Healthcare, Inc. (NYSE:HCA) with an Outperform rating and a $495 price target. The bullish initiation centers on HCA’s targeted capital investments in high-growth geographic markets backed by strong demographic tailwinds. Coupled with compounding efficiency gains from its ongoing “resiliency” program and digital transformation, […]

Yahoo · Sep 23, 2026

HCA Healthcare (HCA) Shares Moved, What Is Driving Attention Today?

HCA Healthcare (HCA) is back in focus after five affiliated Texas hospitals filed suit against Independence Blue Cross, alleging more than $345,000 in unpaid claims between 2022 and 2024. At a share price of US$438.12, HCA Healthcare has seen a 2.85% 1 day share price return and a 12.99% 90 day share price return. Total shareholder return of 7.73% over one year and 80.41% over three years points to momentum that has built over time, even as the year to date share price return is down 6.86%,...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.